Dr. Supriya Shivakumar is Head of Strategy, Gene Editing and Novel Modalities at MillaporeSigma. She started in academic science with a PhD in oncology in the lab of nobel Laureate Harold Varmus at the University of California, San Francisco, followed by a translational research postdoc. Her focus is our innovation, marketing and business development strategies driving gene editing to cell and gene therapy. She states, “I found that my greatest passion is for the intersection of business and cutting edge science.”
